Advertisement

Related Videos

Opening Session Panel Discussion

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Peter Clark, MA, MD, FRCP: A Payer Perspective

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Opportunities to Optimize Cancer Policies Panel Discussion

Advertisement

Advertisement




May
28
Today In Oncology
FDA Approves Durvalumab Plus BCG for High-Risk NMIBC
Local Radiotherapy May Help Control Oligometastatic Breast Cancer
TAILORx and RxPONDER Trials Shift to a Discovery Platform
Radiotherapy for Prostate Cancer: HERMES Trial Compares Two and Five Fractions
BPDCN FDA Approves Pivekimab Sunirine-pvzy
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo